Webinar: Open questions about nano and face masks

Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread of COVID-19 until vaccines or drugs will be available to treat the disease.

Every crisis creates opportunities. In recent months, many Swiss SMEs have been thinking about what makes a good mask. They have scaled up networking, have been experimenting and tinkering and tried out different ways to develop a sustainable high-tech mask made in Switzerland.

But before a new protective mask can be launched on the market either as a respiratory protection mask (Filtering Facepiece mask or FFP) or a surgical mask, a whole series of tests must be run and certificates to guarantee its quality must be obtained. Protective masks containing nanomaterials in particular must meet the requirements of the EU Medical Devices Regulation of 2017.

Having received an increasing number of enquiries about nanoparticles and face masks, contactpointnano.ch has organized a webinar on Nano and masks.


Sergio Bellucci: The national contactpointnano.ch

Peter Wick: Covid-19, face masks and how nanotechnology can provide solutions

Margrit Widmann:  Classification and regulation of protective masks

Wouter Pronk: Antiviral face masks: Industrial experience

Christoph Geers: The Swiss NanoAnalytics platform

Related articles

Country-scale calculation... Plastic particles less than five millimeters in size, also known as microplastics, often settle far away from their point of origin. Empa researchers have now developed a
Publications on Synthetic... Action plan Synthetic Nanomaterials Final report 2 September 2020 (only available in German and French) Opportunities and Risks of Nanomaterials Journal of Nanobiotechnology, 2017 Opportunities and Risks
Reliable knowledge on nan... contactpointnano.ch helps with questions about nanomaterials A new contact point for start-ups, SMEs and industry bundles the scientific and regulatory expertise in the field of nanotechnology available
Clinam Summit in Basel This year, the 14th European and Global Summit for Clinical Nanomedicine (CLINAM Summit) organized by the European Foundation for Clinical Nanomedicine will take place on 8-11 October
Safe-by-design and EU fun... Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
Guidelines: Safe-by-desig... A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises
Nanomedicine in Liverpool contactpointnano was present at Nanomed Europe 23 in Liverpool (June 19-22). This event is organized by ETPN and it is the largest Nanomedicine event in Europe. The
The MACRAMÉ Project, a 36-months research and innovation action, funded by the European Commission’s Horizon Europe Framework Programme, commenced its ambitious, collaborative workprogramme on the characterisation and
Crucial results for coron... Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
NanoGVA Symposium The 2nd NanoGVA Symposium “Creating the Invisible: the development of nanomedicines” will be hosted by the University of Geneva on October 5-6, 2023. The symposium will deal